NYSE:MDTMedical Equipment
Does Antitrust Verdict Targeting Hospital Contracts Change The Bull Case For Medtronic (MDT)?
In early February 2026, a California federal jury found Medtronic liable for anticompetitive conduct in the advanced bipolar surgical devices market and ordered the company to pay more than US$381 million in damages to rival Applied Medical under U.S. and California antitrust laws.
Beyond the large financial penalty, the verdict targets Medtronic’s contracting practices with hospitals and group purchasing organizations, potentially reshaping how its surgical devices compete for...